---
schema_version: "secwatch.filing_event.v1"
accession: "0000721371-25-000128"
form_type: "8-K"
ticker: "CAH"
cik: "0000721371"
company_name: "CARDINAL HEALTH INC"
filed_at: "2025-10-30T23:59:59+00:00"
generated_at: "2026-05-17T01:28:47.178062+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Cardinal Health Q1 revenue $64B (+22%), non-GAAP EPS $2.55 (+36%); raises FY2026 guidance

## Summary
- Revenue $64B (+22% YoY); GAAP diluted EPS $1.88 (+11%); non-GAAP diluted EPS $2.55 (+36%).
- Segment profit growth across all five segments; Pharmaceutical & Specialty profit up 26% to $667M.
- FY2026 non-GAAP EPS guidance raised to $9.65-$9.85 (from $9.30-$9.50); adjusted free cash flow raised to $3.0-$3.5B.
- Acquisition of Solaris Health expected to close early November; initiated $375M accelerated share repurchase in Q1.

## SEC filing metadata
- accession: 0000721371-25-000128
- form_type: 8-K
- ticker: CAH
- cik: 0000721371
- company_name: CARDINAL HEALTH INC
- filed_at: 2025-10-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/721371/000072137125000128/0000721371-25-000128-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/721371/000072137125000128/cah-20251030.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000721371-25-000128
- JSON: https://secwatch.observer/filing/0000721371-25-000128.json
- Plain text: https://secwatch.observer/filing/0000721371-25-000128.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
